Clover Health's CEO Sold Company Shares Worth $1.7 Million. Here's What That Means for Investors.

Clover Health CEO Andrew Toy sold 313,476 shares worth $1.67 million on July 1, 2026, representing a 3.16% reduction in his direct holdings. The sale was a non-discretionary tax withholding event tied to RSU vesting, not a signal of lost confidence. Toy retains 9.6 million shares, maintaining significant alignment with shareholders. The sale comes amid strong company performance, including a court-mandated Medicare rating upgrade and 51% year-over-year membership growth in Q1 2026.